Drug Shortage Report for BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP

Last updated on 2024-01-22 History
Report ID 211218
Drug Identification Number 02460645
Brand name BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP
Common or Proper name BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) BUPIVACAINE HYDROCHLORIDE
Strength(s) 7.5MG
Dosage form(s) SOLUTION
Route of administration INTRASPINAL INTRASPINAL
Packaging size 10 AMPOULES X 2 ML
ATC code N01BB
ATC description ANESTHETICS, LOCAL
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2024-03-27
Actual start date
Estimated end date Unknown
Actual end date
Shortage status Anticipated shortage
Updated date 2024-01-22
Company comments
Health Canada comments
Tier 3 Status Yes
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2024-01-22 English Compare
v2 2023-11-22 French Compare
v1 2023-11-22 English Compare

Showing 1 to 3 of 3